These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20966183)

  • 1. Metabolic syndrome and rare gynecological cancers in the metabolic syndrome and cancer project (Me-Can).
    Nagel G; Concin H; Bjørge T; Rapp K; Manjer J; Hallmans G; Diem G; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stocks T; Tretli S; Ulmer H; Stattin P; Lukanova A
    Ann Oncol; 2011 Jun; 22(6):1339-1345. PubMed ID: 20966183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can).
    Ulmer H; Bjørge T; Concin H; Lukanova A; Manjer J; Hallmans G; Borena W; Häggström C; Engeland A; Almquist M; Jonsson H; Selmer R; Stattin P; Tretli S; Kleiner A; Stocks T; Nagel G
    Gynecol Oncol; 2012 May; 125(2):330-5. PubMed ID: 22330614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study on metabolic risk factors and gallbladder cancer in the metabolic syndrome and cancer (Me-Can) collaborative study.
    Borena W; Edlinger M; Bjørge T; Häggström C; Lindkvist B; Nagel G; Engeland A; Stocks T; Strohmaier S; Manjer J; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
    PLoS One; 2014; 9(2):e89368. PubMed ID: 24586723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.
    Borena W; Strohmaier S; Lukanova A; Bjørge T; Lindkvist B; Hallmans G; Edlinger M; Stocks T; Nagel G; Manjer J; Engeland A; Selmer R; Häggström C; Tretli S; Concin H; Jonsson H; Stattin P; Ulmer H
    Int J Cancer; 2012 Jul; 131(1):193-200. PubMed ID: 21805476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can).
    Strohmaier S; Edlinger M; Manjer J; Stocks T; Bjørge T; Borena W; Häggström C; Engeland A; Nagel G; Almquist M; Selmer R; Tretli S; Concin H; Hallmans G; Jonsson H; Stattin P; Ulmer H
    PLoS One; 2013; 8(1):e54242. PubMed ID: 23372693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
    Bjørge T; Lukanova A; Tretli S; Manjer J; Ulmer H; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Jonsson H; Häggström C; Stattin P; Engeland A
    Int J Epidemiol; 2011 Dec; 40(6):1667-77. PubMed ID: 21984693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic factors and the risk of small intestine cancers: Pooled study of 800 000 individuals in the metabolic syndrome and cancer project.
    Nagel G; Bjørge T; Jaensch A; Peter RS; Häggström C; Lang A; Engeland A; Teleka S; Jirström K; Lindquist D; Stattin P; Ulmer H; Concin H; Stocks T
    Int J Cancer; 2021 Jul; 149(1):66-74. PubMed ID: 33634882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can).
    Nagel G; Bjørge T; Stocks T; Manjer J; Hallmans G; Edlinger M; Häggström C; Engeland A; Johansen D; Kleiner A; Selmer R; Ulmer H; Tretli S; Jonsson H; Concin H; Stattin P; Lukanova A
    Br J Dermatol; 2012 Jul; 167(1):59-67. PubMed ID: 22530854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increased body mass index in young adults is associated with metabolic syndrome].
    Kadoya M; Nakamura S; Sugio Y; Hiraoka H; Kurita M; Harada A; Matsumoto M; Nakanishi R; Sugiura T
    Sangyo Eiseigaku Zasshi; 2014; 56(5):121-7. PubMed ID: 24999022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of metabolic syndrome and C-reactive protein with mortality from total cancer, obesity-linked cancers and breast cancer among women in NHANES III.
    Gathirua-Mwangi WG; Song Y; Monahan PO; Champion VL; Zollinger TW
    Int J Cancer; 2018 Aug; 143(3):535-542. PubMed ID: 29488212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective Associations of Serum Adiponectin, Leptin, and Leptin-Adiponectin Ratio with Incidence of Metabolic Syndrome: The Korean Genome and Epidemiology Study.
    Lee KW; Shin D
    Int J Environ Res Public Health; 2020 May; 17(9):. PubMed ID: 32397260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soft drink consumption is associated with increased incidence of the metabolic syndrome only in women.
    Kang Y; Kim J
    Br J Nutr; 2017 Jan; 117(2):315-324. PubMed ID: 28166856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Protective Effects of Increasing Serum Uric Acid Level on Development of Metabolic Syndrome.
    Yu TY; Jin SM; Jee JH; Bae JC; Lee MK; Kim JH
    Diabetes Metab J; 2019 Aug; 43(4):504-520. PubMed ID: 30877704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and its component traits present gender-specific association with liver cancer risk: a prospective cohort study.
    Xia B; Peng J; Enrico T; Lu K; Cheung EC; Kuo Z; He Q; Tang Y; Liu A; Fan D; Zhang C; He Y; Pan Y; Yuan J
    BMC Cancer; 2021 Oct; 21(1):1084. PubMed ID: 34620113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
    Häggström C; Stocks T; Rapp K; Bjørge T; Lindkvist B; Concin H; Engeland A; Manjer J; Ulmer H; Selmer R; Tretli S; Hallmans G; Jonsson H; Stattin P
    Int J Cancer; 2011 Apr; 128(8):1890-8. PubMed ID: 20568111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midlife metabolic factors and prostate cancer risk in later life.
    Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
    Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and esophageal and gastric cancer.
    Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
    Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency is associated with metabolic syndrome in postmenopausal women.
    Schmitt EB; Nahas-Neto J; Bueloni-Dias F; Poloni PF; Orsatti CL; Petri Nahas EA
    Maturitas; 2018 Jan; 107():97-102. PubMed ID: 29169589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and gender-specific distribution of metabolic syndrome components in East China: role of hypertriglyceridemia in the SPECT-China study.
    Jiang B; Zheng Y; Chen Y; Chen Y; Li Q; Zhu C; Wang N; Han B; Zhai H; Lin D; Lu Y
    Lipids Health Dis; 2018 Apr; 17(1):92. PubMed ID: 29678174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
    Bjørge T; Lukanova A; Jonsson H; Tretli S; Ulmer H; Manjer J; Stocks T; Selmer R; Nagel G; Almquist M; Concin H; Hallmans G; Häggström C; Stattin P; Engeland A
    Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1737-45. PubMed ID: 20615887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.